CD4 and hepatocellular carcinoma: Li et al. [29] found that anti-Tim-3 mAb could enhance Ki67 expression and IL-2 and IFN-γ production in Tim-3+CD4+ T cells cocultured with HCC-derived Gal-9+ TAMs by blocking the interaction of Gal-9 with Tim-3.